Article Details

Goldman initiated coverage on Protagonist Therapeutics with a new price target

Retrieved on: 2024-12-07 01:27:14

Tags for this article:

Click the tags to see associated articles and topics

Goldman initiated coverage on Protagonist Therapeutics with a new price target. View article details on hiswai:

Excerpt

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate ... Biotechnology: Biological ...

Article found on: quantisnow.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo